Abstract
All French laboratories that routinely assay estradiol (ER) and progesterone (PR) receptors participate in the European EORTC quality control program based on twice-yearly analysis of 5 cytosolic preparations. This system has considerably reduced inter-laboratory variations, but does not cover all aspects of these assays. Analysis of receptor value distributions is also crucial to ensure that receptor measurements remain stable with time, independently of the laboratory and assay method. This study involved 83907 receptor assays carried out in the last 17 years by 17 laboratories belonging to the French Study Group on Tissue and Molecular Biopathology. The assays were based on radioligand binding (RLA) or immunoenzymology (EIA). For each laboratory, the medians and positivity rates were analysed according to two totally objective criteria, the patient's age and the year of assay, and according to histological grade and histological type of the tumor in order to verify the correlations classically described. Age-related distributions varied little between laboratories, compared with data published by 7 European EORTC laboratories [1]. The results remained relatively stable with time in the RLA method for ER and PR, and in the EI...Continue Reading
References
Jan 1, 1979·Cancer Chemotherapy and Pharmacology·P M MartinM Toga
Jan 1, 1990·Acta Oncologica·M FernöG Sellberg
Jan 1, 1989·Acta Oncologica·N WilkingL Skoog
Jan 5, 1985·Lancet·C RoseB B Rasmussen
Jan 1, 1988·Acta Oncologica·S M Thorpe
Apr 1, 1987·European Journal of Cancer & Clinical Oncology·J M RaemaekersP W Kloppenborg
Aug 1, 1986·European Journal of Cancer & Clinical Oncology·S M Thorpe, A Koenders
Aug 1, 1986·European Journal of Cancer & Clinical Oncology·A Koenders, S M Thorpe
Oct 1, 1985·World Journal of Surgery·C RoseK W Andersen
May 1, 1973·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Nov 1, 1980·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Sep 1, 1983·European Journal of Cancer & Clinical Oncology·A Koenders, S M Thorpe
Oct 1, 1983·European Journal of Cancer & Clinical Oncology·A Koenders, S M Thorpe
Dec 15, 1980·Cancer·R ParidaensJ C Heuson
Jan 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S RomainH Magdelenat
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S M Thorpe
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S RomainP M Martin
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R A WeigandD Cotter
Sep 1, 1994·Cancer·P PujolR M Elledge
Apr 1, 1994·International Journal of Cancer. Journal International Du Cancer·H MagdelénatB Dutrillaux
Sep 1, 1957·British Journal of Cancer·H J BLOOM, W W RICHARDSON
Citations
Aug 24, 2000·International Journal of Cancer. Journal International Du Cancer·S RomainP M Martin
Jul 6, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Chafika MazouniPierre-Marie Martin
Sep 15, 2001·Applied Immunohistochemistry & Molecular Morphology : AIMM·M Ferrero-PoüsF Spyratos
Mar 31, 1999·British Journal of Cancer·S M EngerL Bernstein
Feb 16, 2006·The Oncologist·M Tish Knobf
Jun 2, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P BroëtF Spyratos